Innovation
11 patent families (6 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 624 times.
| Year | Filings |
|---|---|
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 2 |
Social engagement
Social engagement: 18.6K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
4 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |
Recent activity
10 Jun 2026
Event
PrideMax CPG siRNA CPG webinar
4 Jun 2026
Product launch
Lucigen Reagent Components
26 May 2026
Event
PrimeMaxTM siRNA CPG Webinar